Fentanyl, the Overdose Crisis & Cartels

The challenge

What's the Challenge?

Synthetic opioids—principally fentanyl—are the leading cause of death for American adults under 50 and have killed more than 100,000 Americans per year in recent years, though provisional 2024 and 2025 data show meaningful declines from the peak. Most fentanyl is produced by Mexican cartels using precursor chemicals largely sourced from China, then smuggled into the United States primarily by U.S. citizens at official border crossings. The Trump administration in 2025 designated several major cartels as Foreign Terrorist Organizations and pursued aggressive border enforcement; debate has intensified over whether and how the U.S. military could be used against cartels operating in Mexico without that country's consent. Public health advocates argue overdose deaths cannot be solved with enforcement alone—treatment access, harm reduction, and stable mental healthcare matter at least as much. Critics argue decades of demand-side policy have failed and that supply-side disruption deserves a much bigger role.

Where we agree

Where Most Americans Agree

The overdose crisis is a public health emergency that demands a serious national response
Mexican cartels are dangerous, well-armed criminal organizations that harm Americans and Mexicans alike
China-sourced precursor chemicals are part of the problem and need diplomatic and enforcement pressure
Addiction is both a public health and a criminal justice issue, not one or the other
Treatment, recovery support, and mental healthcare access need expansion
First responders, families, and communities on the front lines need more support
Stopping the flow of fentanyl at the border is a legitimate priority

Source · Pew Research Center, KFF, RAND Drug Policy Research Center 2024-2025

Both sides, fairly

How each side argues it.

Understanding the full debate means reading what each side actually says, not the caricature of it.

Progressive

Progressive Perspective

Decades of supply-side enforcement haven't stopped drug crises; expanding treatment, naloxone access, and harm reduction saves lives now
Most fentanyl is smuggled through legal ports of entry by U.S. citizens—a border wall does not address that vector
Designating cartels as terrorists and contemplating U.S. military strikes inside Mexico risks war and undermines the cooperation needed to actually disrupt them
Recent declines in overdose deaths track expanded access to naloxone, methadone, and buprenorphine—evidence that the public-health approach works
Mental illness, untreated pain, and economic despair are root causes that punishment cannot fix
Criminalizing users without offering treatment fills prisons without reducing supply or demand

Conservative

Conservative Perspective

Cartels are paramilitary organizations behaving like terrorists; treating them that way unlocks tools to disrupt them
Securing the border—including disrupting the smuggling networks—is essential to reducing supply
China's failure to crack down on precursor exports is a deliberate hostile act and should bear costs
Aggressive prosecution of traffickers, especially those dealing fatal doses, is justice for victims and their families
Permissive policies that tolerate open drug use entrench addiction and harm communities
While treatment matters, treating supply-side enforcement as a failure ignores how much worse the crisis would be without it

The evidence

Evidence-Based Facts

№ 01
U.S. drug-overdose deaths peaked at roughly 111,000-112,000 in 2023, with synthetic opioids (mainly fentanyl) involved in about 70% of those deaths; provisional CDC data show meaningful declines in 2024 and 2025
Source · CDC National Center for Health Statistics; CDC Provisional Drug Overdose Death Counts
№ 02
DEA and CBP data indicate the great majority of fentanyl seized at the border is intercepted at official ports of entry; about 80-90% of fentanyl-trafficking convictions involve U.S. citizens
Source · Drug Enforcement Administration; U.S. Sentencing Commission
№ 03
In February 2025 the U.S. government designated six Mexican cartels and several other transnational criminal groups as Foreign Terrorist Organizations
Source · U.S. Department of State
№ 04
Medications for opioid use disorder (methadone, buprenorphine, naltrexone) reduce overdose mortality by roughly half in randomized and observational studies
Source · National Institute on Drug Abuse; New England Journal of Medicine reviews
№ 05
China announced in 2019 broader scheduling of fentanyl analogues but enforcement of precursor chemical exports has been a continuing point of contention between U.S. and Chinese officials
Source · Congressional Research Service

Read deeper

Learn More

Honest questions

Questions for Thoughtful Debate

№ 01
What's the right balance between supply-side enforcement and demand-side treatment and prevention?
№ 02
Should the U.S. military be used against cartels in Mexico—and under what legal authority?
№ 03
Has the cartel terrorist designation made the problem easier or harder to manage diplomatically?
№ 04
How should we measure progress: overdose deaths, drug seizures, prosecutions, treatment access, or all of the above?
№ 05
What role should harm reduction (naloxone, syringe services) play in federal and state policy?
№ 06
How can China and the U.S. cooperate to disrupt precursor chemical supply chains?